PRESS RELEASE published on 01/22/2024 at 16:00, 2 years 3 months ago Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters Zentek Ltd. announces the completion of a new study showing significant energy and cost savings for commercial buildings adopting ZenGUARDTM Enhanced Air Filters. The study highlights the reduction of infection risk and the potential to reduce HVAC energy consumption and CO2 emissions. Find out more on Zentek's website. Zentek Ltd. ZenGUARDTM Enhanced Air Filters HVAC Energy Consumption CO2 Emissions Commercial Buildings
PRESS RELEASE published on 01/19/2024 at 14:45, 2 years 3 months ago Zentek Announces Eric Wallman Appointed as Chairman of the Board Zentek Ltd., an intellectual property development and commercialization company, announces the resignation of Dr. Francis Dubé as Chairman of the Board and the appointment of Mr. Eric Wallman as the new Chairman according to best practices in governance. The company continues to focus on research, development, and commercialization of novel products, including their patented technology platform, ZenGUARD™, known for its anti-microbial activity and increased filtration efficiency. Zentek Ltd. Intellectual Property Development Governance Best Practices ZenGUARD Technology Commercialization Company
PRESS RELEASE published on 12/13/2023 at 21:30, 2 years 4 months ago Zentek Launches Triera Biosciences Ltd.
PRESS RELEASE published on 12/08/2023 at 14:15, 2 years 4 months ago Zentek and 1Click Heating and Cooling Sign Distribution Agreement
PRESS RELEASE published on 12/01/2023 at 03:17, 2 years 5 months ago Zentek Announces Grant of Stock Options Zentek Ltd. announces the granting of 400,000 stock options to a director and officer, exercisable at $1.75 per share, with vesting schedule. Zentek focuses on patent technology for novel products Stock Options Patented Technology Zentek Ltd. Intellectual Property Zentek News
PRESS RELEASE published on 11/29/2023 at 16:00, 2 years 5 months ago Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant
PRESS RELEASE published on 11/21/2023 at 14:20, 2 years 5 months ago Zentek Announces Update on the Albany Graphite Project
PRESS RELEASE published on 11/15/2023 at 14:15, 2 years 5 months ago Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology
PRESS RELEASE published on 10/17/2023 at 15:10, 2 years 6 months ago Zentek Completes Return on Investment Analysis for Canadian Healthcare System
PRESS RELEASE published on 10/10/2023 at 15:18, 2 years 6 months ago Zentek Announces Successful Aptamer Testing for Longevity of Protection and Minimum Effective Dose
Published on 05/07/2026 at 05:40, 2 hours 42 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 6 hours 22 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 8 hours 52 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours 17 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 9 hours 22 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 08:05, 17 minutes ago Hyundai Mobis Develops Power Electric Systems Ready to All EV Models
Published on 05/07/2026 at 08:05, 17 minutes ago Nota AI Signs AI Optimization Technology Supply and Strategic Partnership Agreement with Mobilint Accelerating Commercialization of On-Device AI on Domestic NPU Infrastructure
Published on 05/07/2026 at 08:00, 22 minutes ago Financial results Q1 2026 – Strong, profitable growth
Published on 05/07/2026 at 08:00, 22 minutes ago AIXTRON supplied Planetary GaN MOCVD Systems to Renesas for High-Volume Manufacturing Expansion
Published on 05/07/2026 at 08:00, 22 minutes ago Pentixapharm Reports First Quarter 2026 Results and Highlights Clinical and Regulatory Momentum
Published on 05/06/2026 at 18:00, 14 hours 22 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 14 hours 22 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 14 hours 22 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026